Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study.

[1]  W. Willett,et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.

[2]  M. Nieminen,et al.  Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[3]  J. Huttunen,et al.  Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. , 1991, Atherosclerosis.

[4]  R. Clarke,et al.  Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.

[5]  L. Taylor,et al.  The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. , 1991, Journal of vascular surgery.

[6]  L. Wilhelmsen,et al.  Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. , 1990, BMJ.

[7]  S. Hunt,et al.  Hyperhomocyst(e)inemia in Utah siblings with early coronary disease , 1990 .

[8]  P. Wilson,et al.  Plasma homocyst(e)ine levels in men with premature coronary artery disease. , 1990, Journal of the American College of Cardiology.

[9]  D. Rosenblatt,et al.  Detection of heterozygotes for recessive alleles. Homocyst(e)inemia: paradigm of pitfalls in phenotypes. , 1990, American journal of medical genetics.

[10]  M. Malinow,et al.  Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. , 1990, Stroke.

[11]  M. Malinow,et al.  Homocyst(e)inemia in daily practice: levels in coronary artery disease , 1990 .

[12]  B. Norrving,et al.  Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. , 1990, Atherosclerosis.

[13]  G. Assmann,et al.  Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. , 1990, Clinical chemistry.

[14]  G. Utermann,et al.  The mysteries of lipoprotein(a). , 1989, Science.

[15]  P. Ueland,et al.  Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. , 1989, The Journal of laboratory and clinical medicine.

[16]  T. Kita,et al.  Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. , 1989, Atherosclerosis.

[17]  L. Taylor,et al.  Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. , 1989, Circulation.

[18]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .

[19]  S. Mudd.  Disorders of transsulfuration , 1989 .

[20]  G. Dahlén,et al.  Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. , 1989, European heart journal.

[21]  G. Hoefler,et al.  Lipoprotein Lp(a): A Risk Factor for Myocardial Infarction , 1988, Arteriosclerosis.

[22]  B. Israelsson,et al.  Homocysteine and myocardial infarction. , 1988, Atherosclerosis.

[23]  J. Jeppsson,et al.  Folic acid--an innocuous means to reduce plasma homocysteine. , 1988, Scandinavian journal of clinical and laboratory investigation.

[24]  E. Podell,et al.  Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. , 1988, The Journal of clinical investigation.

[25]  Dahlén Gh.  Lipoprotein (a) in relation to atherosclerotic diseases. , 1988 .

[26]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[27]  A. Chait,et al.  The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. , 1987, The Journal of biological chemistry.

[28]  S. Parthasarathy.  Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. , 1987, Biochimica et biophysica acta.

[29]  Y. Sako,et al.  Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. , 1987, Journal of chromatography.

[30]  V. Armstrong,et al.  The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. , 1986, Atherosclerosis.

[31]  N. Morton,et al.  Lp(a) lipoprotein as a risk factor for myocardial infarction. , 1986, JAMA.

[32]  A. Gotto,et al.  CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography , 2022 .

[33]  K.,et al.  Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. , 1986, The Journal of clinical investigation.

[34]  M. Kameyama,et al.  Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. , 1986, Atherosclerosis.

[35]  A. Antony,et al.  Isolation and characterization of methionine synthetase from human placenta. , 1985, The Journal of biological chemistry.

[36]  F. Feit,et al.  Methionine intolerance: a possible risk factor for coronary artery disease. , 1985, Journal of the American College of Cardiology.

[37]  G. Boers,et al.  Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.

[38]  K. Pettigrew,et al.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency. , 1985, American journal of human genetics.

[39]  G. Utermann,et al.  Protein composition of Lp(a) lipoprotein from human plasma , 1983, FEBS letters.

[40]  H. Rothschild.  Biocultural aspects of diseases. , 1981 .

[41]  E Marth,et al.  Lipoprotein Lp(a) and the risk for myocardial infarction. , 1981, Atherosclerosis.

[42]  N. Breslow,et al.  The analysis of case-control studies , 1980 .

[43]  P. Hekali,et al.  Serum lipids in angiographically assessed coronary atherosclerosis. , 1978, Chest.

[44]  R. Ross,et al.  Homocystinemia. Vascular injury and arterial thrombosis. , 1974, The New England journal of medicine.

[45]  C. Ehnholm,et al.  The Occurrence of Ag Determinants in Different Lipoproteins , 1973, Vox sanguinis.

[46]  C. Ehnholm,et al.  Protein and carbohydrate composition of Lp(a)lipoprotein from human plasma. , 1972, Biochemistry.

[47]  J. Finkelstein,et al.  Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity. , 1972, Biochemical and biophysical research communications.

[48]  C. Ehnholm,et al.  Purification and quantitation of the human plasma lipoprotein carrying the Lp(a) antigen. , 1971, Biochimica et biophysica acta.

[49]  C. Ehnholm,et al.  Characterization of the Lp(a) lipoprotein in human plasma. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[50]  Seymour Geisser,et al.  Statistical Principles in Experimental Design , 1963 .